Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3400299
Max Phase: Preclinical
Molecular Formula: C42H63N15O12
Molecular Weight: 970.06
Molecule Type: Small molecule
Associated Items:
ID: ALA3400299
Max Phase: Preclinical
Molecular Formula: C42H63N15O12
Molecular Weight: 970.06
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NC(=O)[C@H](CO)NC(=O)CCCCCn1cc(COc2cc(OCc3cn(CCCCCC(=O)N[C@@H](CO)C(N)=O)nn3)cc(OCc3cn(CCCCCC(=O)N[C@@H](CO)C(N)=O)nn3)c2)nn1
Standard InChI: InChI=1S/C42H63N15O12/c43-40(64)34(22-58)46-37(61)10-4-1-7-13-55-19-28(49-52-55)25-67-31-16-32(68-26-29-20-56(53-50-29)14-8-2-5-11-38(62)47-35(23-59)41(44)65)18-33(17-31)69-27-30-21-57(54-51-30)15-9-3-6-12-39(63)48-36(24-60)42(45)66/h16-21,34-36,58-60H,1-15,22-27H2,(H2,43,64)(H2,44,65)(H2,45,66)(H,46,61)(H,47,62)(H,48,63)/t34-,35-,36-/m0/s1
Standard InChI Key: CLLJHFSIBAVJLI-KVBYWJEESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 970.06 | Molecular Weight (Monoisotopic): 969.4781 | AlogP: -2.23 | #Rotatable Bonds: 36 |
Polar Surface Area: 397.08 | Molecular Species: NEUTRAL | HBA: 21 | HBD: 9 |
#RO5 Violations: 3 | HBA (Lipinski): 27 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.37 | CX Basic pKa: 0.34 | CX LogP: -3.43 | CX LogD: -3.43 |
Aromatic Rings: 4 | Heavy Atoms: 69 | QED Weighted: 0.02 | Np Likeness Score: -0.40 |
1. Elshan NG, Jayasundera T, Weber CS, Lynch RM, Mash EA.. (2015) Development of a time-resolved fluorescence probe for evaluation of competitive binding to the cholecystokinin 2 receptor., 23 (8): [PMID:25769518] [10.1016/j.bmc.2015.02.028] |
Source(1):